SU1666116A1 - Method for treatment of trifacial neuralgia - Google Patents
Method for treatment of trifacial neuralgia Download PDFInfo
- Publication number
- SU1666116A1 SU1666116A1 SU894667447A SU4667447A SU1666116A1 SU 1666116 A1 SU1666116 A1 SU 1666116A1 SU 894667447 A SU894667447 A SU 894667447A SU 4667447 A SU4667447 A SU 4667447A SU 1666116 A1 SU1666116 A1 SU 1666116A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- branch
- myelopid
- neuralgia
- patient
- treatment
- Prior art date
Links
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относитс к области медицины, а именно к неврологии. Способ позвол ет сократить сроки лечени , что достигаетс назначением препаратов группы карбамазепина и дополнительно иммуномодулирующего препарата - миелопида.This invention relates to the field of medicine, namely to neurology. The method makes it possible to shorten the treatment time, which is achieved by prescribing drugs of the carbamazepine group and, additionally, an immunomodulating drug, myelopid.
Description
Изобретение относитс к медицине, а именно к неврологии.The invention relates to medicine, namely to neurology.
Цель изобретени - сокращение сроков лечени .The purpose of the invention is to reduce the duration of treatment.
Способ осуществл ют следующим образом .The method is carried out as follows.
Больному назначают лечение препаратами карбамазепина 0,1x2 раза в день и дополнительно миелопид в виде подкожных инъекций, которые готов т extempore в дозе 0,002-0,004 г на 1 см3 физиологического рартвора. Миелопид ввод т через день, курс лечени 4-5 инъекций.The patient is prescribed treatment with carbamazepine 0.1x2 times a day and additionally mielopid in the form of subcutaneous injections, which is prepared extempore at a dose of 0.002-0.004 g per 1 cm3 of physiological solution. Myelopid is administered every other day, a course of treatment is 4-5 injections.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU894667447A SU1666116A1 (en) | 1989-04-05 | 1989-04-05 | Method for treatment of trifacial neuralgia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU894667447A SU1666116A1 (en) | 1989-04-05 | 1989-04-05 | Method for treatment of trifacial neuralgia |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1666116A1 true SU1666116A1 (en) | 1991-07-30 |
Family
ID=21436521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU894667447A SU1666116A1 (en) | 1989-04-05 | 1989-04-05 | Method for treatment of trifacial neuralgia |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1666116A1 (en) |
-
1989
- 1989-04-05 SU SU894667447A patent/SU1666116A1/en active
Non-Patent Citations (1)
Title |
---|
Карлов В.А. Терапи нервных болезней. М.: Медицина. 1987, с. 473-478. * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kaji et al. | Effect of ultrahigh‐dose methylcobalamin on compound muscle action potentials in amyotrophic lateral sclerosis: A double‐blind controlled study | |
RU2001116077A (en) | A method for the treatment of cerebral ischemia, as well as the use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischemia | |
DE69230112T2 (en) | ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE | |
DE69024053D1 (en) | TREATMENT TO REDUCE EDM AND MUSCLE DAMAGE. | |
CN1133461C (en) | Application of tigroid spider toxic extract in preparing analgesic | |
SU1666116A1 (en) | Method for treatment of trifacial neuralgia | |
GB2171302A (en) | Therapeutic hydroxyprolines | |
ES2159661T3 (en) | USE OF A MUSCARINIC ANTAGONIST FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT AND CONTROL OF EYE DEVELOPMENT. | |
Kaada et al. | Analgesia induced by trigeminal nerve stimulation (electro-acupuncture) abolished by nuclei raphe lesions in rats | |
Cohen et al. | The anticonvulsant action of dilantin on sound-induced seizures in the rat. | |
RU1822775C (en) | Method for treatment of trigeminal nerve neuralgia | |
Goodman et al. | Anticonvulsant Properties of 5, 5-Phenyl Thienyl Hydantoin in Comparison with Dilantin and Mesantion. | |
Kapoor et al. | Myoclonic epilepsy in an HIV positive patient: neurophysiological findings | |
Gerst et al. | Lithium-induced improvement of myotonia. | |
SU1560214A1 (en) | Method of treating phantom limb pain | |
SU1487907A1 (en) | Method of treating ovular paints | |
COPPEN | The role of lithium carbonate in the treatment and prophylaxis of the affective disorders | |
Bisgaard | Further Contributions to the Problem of the Function of the Parathyroid Glands and the Pathogenesis of true Epilepsy | |
RU2005459C1 (en) | Method for treating endocrine sterility in women | |
Funcke et al. | Protective action of cyclandelate in hypoxia | |
SU1364340A1 (en) | Method of treatment of chronic glomerulonephritis complicated with nephrotic syndrome | |
SU1706624A1 (en) | Method for curing opiumism and morphinism | |
Lim et al. | Effect of captopril on the vascular permeability changes induced by C5a, histamine and compound 48/80 | |
RU2014020C1 (en) | Method of treating styloiditis | |
BG62759B1 (en) | Means and method for treating auto-immune diseases and method of treatment |